{"id":"short-dapt","safety":{"commonSideEffects":[{"rate":"5-10%","effect":"Bleeding"},{"rate":"1-5%","effect":"Thrombocytopenia"},{"rate":"1-5%","effect":"Acute kidney injury"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Short DAPT typically involves a shorter duration of dual antiplatelet therapy compared to standard DAPT, which can reduce the risk of bleeding complications while still providing adequate cardiovascular protection. This approach is often used in patients undergoing percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).","oneSentence":"Short DAPT involves a reduced duration of dual antiplatelet therapy to minimize bleeding risks while maintaining cardiovascular protection.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:34:23.227Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrial fibrillation for stroke prevention"},{"name":"Acute coronary syndrome"}]},"trialDetails":[{"nctId":"NCT06321757","phase":"","title":"PREVAIL Paclitaxel-coated Balloon in Small Coronary Disease and High-bleeding Risk Patients","status":"RECRUITING","sponsor":"Fundación EPIC","startDate":"2024-02-26","conditions":"Coronary Artery Disease","enrollment":501},{"nctId":"NCT07198529","phase":"NA","title":"OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina","status":"RECRUITING","sponsor":"Korea University Guro Hospital","startDate":"2025-09-30","conditions":"Stable Angina, Coronary Artery Disease","enrollment":130},{"nctId":"NCT05650411","phase":"NA","title":"Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)","status":"NOT_YET_RECRUITING","sponsor":"IGLESIAS Juan Fernando","startDate":"2026-03-01","conditions":"Left Main Coronary Artery Stenosis","enrollment":828},{"nctId":"NCT07238764","phase":"NA","title":"OCT-based DAPT Cessation in HBR Patients","status":"COMPLETED","sponsor":"Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health","startDate":"2022-06-12","conditions":"High Bleeding Risk Patients, DAPT(Dual Antiplatelet Therapy), Coronary Artery Disease","enrollment":40},{"nctId":"NCT07164859","phase":"PHASE3","title":"Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI","status":"NOT_YET_RECRUITING","sponsor":"Vincent ROULE","startDate":"2025-10","conditions":"Coronary Artery Disease (CAD), Percutaneous Coronary Intervention (PCI), Antiplatelet Therapy","enrollment":1700},{"nctId":"NCT05491200","phase":"PHASE4","title":"Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients","status":"RECRUITING","sponsor":"Research Maatschap Cardiologen Rotterdam Zuid","startDate":"2022-07-22","conditions":"ST Elevated Myocardial Infarction, Dual Antiplatelet Therapy","enrollment":1656},{"nctId":"NCT04753749","phase":"NA","title":"Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy","status":"COMPLETED","sponsor":"MicroPort CRM","startDate":"2021-03-25","conditions":"Myocardial Infarction, Acute, Coronary Artery Disease","enrollment":2248},{"nctId":"NCT07080684","phase":"PHASE4","title":"Short-Term Dual Antiplatelet Therapy With Early Transi-tion to Low-dose Antiplatelet Monotherapy Using Ti-cagRelor in Chronic Coronary Artery Disease","status":"NOT_YET_RECRUITING","sponsor":"University of Messina","startDate":"2025-12-01","conditions":"Chronic Coronary Syndrome","enrollment":1000},{"nctId":"NCT03447379","phase":"NA","title":"Short-term Dual Antiplatelet Therapy After Deployment of Bioabsorbable Polymer Everolimus-eluting Stent","status":"COMPLETED","sponsor":"Gangnam Severance Hospital","startDate":"2017-12-15","conditions":"Coronary Artery Disease","enrollment":1452},{"nctId":"NCT06718179","phase":"PHASE4","title":"Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients with Acute Coronary Syndromes Treated with Percutaneous Coronary Intervention and Everolimus-eluting Stents","status":"RECRUITING","sponsor":"Odense University Hospital","startDate":"2024-11-16","conditions":"Acute Coronary Syndrome","enrollment":3150},{"nctId":"NCT06075420","phase":"","title":"Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease","status":"RECRUITING","sponsor":"Genoss Co., Ltd.","startDate":"2021-08-18","conditions":"Percutaneous Coronary Intervention, Dual Antiplatelet Therapy","enrollment":1000},{"nctId":"NCT05476081","phase":"","title":"A REAl-life Study on Short-term DAPT in Patients With Ischemic Stroke or TIA","status":"COMPLETED","sponsor":"University of L'Aquila","startDate":"2021-02-03","conditions":"Ischemic Stroke, TIA","enrollment":2239},{"nctId":"NCT06683300","phase":"","title":"Drug Eluting Stenting and Short Dual Antiplatelet Therapy for Preventing Recurrent Stroke in Vertebral Stenosis Registry Study","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-11","conditions":"Vertebral Artery Stenosis","enrollment":520},{"nctId":"NCT05320926","phase":"NA","title":"Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2022-07-26","conditions":"Ischemic Heart Disease","enrollment":3744},{"nctId":"NCT05660811","phase":"PHASE4","title":"Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure in Dialyzed Patients","status":"RECRUITING","sponsor":"National Institute of Cardiology, Warsaw, Poland","startDate":"2022-09-28","conditions":"Atrial Fibrillation","enrollment":80},{"nctId":"NCT02619760","phase":"PHASE4","title":"ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study","status":"COMPLETED","sponsor":"Kyoto University, Graduate School of Medicine","startDate":"2015-12","conditions":"Coronary Artery Disease","enrollment":3045},{"nctId":"NCT04609111","phase":"PHASE4","title":"ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-3 Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kyoto University, Graduate School of Medicine","startDate":"2021-01-29","conditions":"Acute Coronary Syndrome","enrollment":6002},{"nctId":"NCT03462498","phase":"PHASE4","title":"ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kyoto University, Graduate School of Medicine","startDate":"2018-04-02","conditions":"Acute Coronary Syndrome, Acute Myocardial Infarction, Coronary Artery Disease","enrollment":3008},{"nctId":"NCT05204212","phase":"NA","title":"Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease","status":"RECRUITING","sponsor":"Prof. Dr. med. Ingo Eitel","startDate":"2022-03-28","conditions":"Non-valvular Atrial Fibrillation (NVAF): Paroxysmal, Persistent, Permanent","enrollment":430},{"nctId":"NCT05262803","phase":"PHASE4","title":"Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction","status":"RECRUITING","sponsor":"Rikke Sorensen","startDate":"2022-06-17","conditions":"Myocardial Infarction","enrollment":2808},{"nctId":"NCT02099617","phase":"NA","title":"Efficacy and Safety of New Generation Drug Eluting Stents Associated With an Ultra Short Duration of Dual Antiplatelet Therapy. Design of the Short Duration of Dual antiplatElet Therapy With SyNergy II Stent in Patients Older Than 75 Years Undergoing Percutaneous Coronary Revascularization.","status":"COMPLETED","sponsor":"Ceric Sàrl","startDate":"2014-05","conditions":"Stable Angina, Silent Myocardial Ischemia, Acute Coronary Syndrome","enrollment":1200},{"nctId":"NCT06084000","phase":"NA","title":"STrategies of Scheduled Drug-coated Balloons (DCB) Versus Conventional DES for the interveNTional Therapy of de Novo Lesions in Large Coronary vESSels (STENTLESS) Trial","status":"UNKNOWN","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2023-10-15","conditions":"Drug-coated Balloon, Drug-eluting Stent, De Novo Stenosis","enrollment":2700},{"nctId":"NCT03445949","phase":"PHASE4","title":"Optimal Antiplatelet Therapy Following Left Atrial Appendage Closure","status":"RECRUITING","sponsor":"National Institute of Cardiology, Warsaw, Poland","startDate":"2018-01-23","conditions":"Atrial Fibrillation","enrollment":200},{"nctId":"NCT03797651","phase":"NA","title":"Ticagrelor Monotherapy in PAtients Treated With New-generation Drug-eluting Stents for Acute Coronary Syndrome; T-PASS Trial","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2019-04-24","conditions":"Coronary Artery Disease, Acute Coronary Syndrome","enrollment":2850},{"nctId":"NCT02601157","phase":"PHASE4","title":"Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis - Coronary Intervention With Next Generation Drug-Eluting Stent Platforms and Abbreviated Dual Antiplatelet Therapy (HOST-IDEA) Trial","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2016-01-18","conditions":"Stable Angina, Unstable Angina, Non-ST Segment Elevation Myocardial Infarction","enrollment":2173},{"nctId":"NCT05240781","phase":"NA","title":"Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk","status":"UNKNOWN","sponsor":"Instituto Nacional de Cardiologia Ignacio Chavez","startDate":"2021-09-29","conditions":"High Bleeding Risk, Coronary Artery Disease, Percutaneous Coronary Intervention","enrollment":280},{"nctId":"NCT04850417","phase":"PHASE4","title":"Randomized Study of Beta-Blockers and Antiplatelets in Patients With Spontaneous Coronary Artery Dissection","status":"NOT_YET_RECRUITING","sponsor":"Spanish Society of Cardiology","startDate":"2021-04-30","conditions":"Spontaneous Coronary Artery Dissection","enrollment":600},{"nctId":"NCT03355742","phase":"NA","title":"XIENCE 28 Global Study","status":"COMPLETED","sponsor":"Abbott Medical Devices","startDate":"2018-02-09","conditions":"Bleeding Disorder, Stroke, Ischemic, Stroke Hemorrhagic","enrollment":963},{"nctId":"NCT02605447","phase":"PHASE4","title":"EVOLVE Short DAPT Study","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2016-02-16","conditions":"Coronary Artery Disease","enrollment":2009},{"nctId":"NCT02513810","phase":"NA","title":"A Randomized Controlled Comparison Between One Versus More Than Six Months of Dual Antiplatelet Therapy After Biolimus A9-eluting Stent Implantation","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2015-12-02","conditions":"Coronary Artery Disease","enrollment":3020},{"nctId":"NCT02798913","phase":"PHASE3","title":"Effects of Prolonged DAPT After Lower Extremity Percutaneous Transluminal Angioplasty (PTA) in Patients With LE-PAD","status":"UNKNOWN","sponsor":"Federico II University","startDate":"2016-01","conditions":"Peripheral Artery Disease","enrollment":300},{"nctId":"NCT02118870","phase":"PHASE4","title":"Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent","status":"COMPLETED","sponsor":"Diagram B.V.","startDate":"2014-06-10","conditions":"Acute Coronary Syndrome","enrollment":1500},{"nctId":"NCT02494284","phase":"PHASE4","title":"Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation","status":"TERMINATED","sponsor":"CHEOL WHAN LEE, M.D., Ph.D","startDate":"2015-12-22","conditions":"Coronary Artery Disease","enrollment":364},{"nctId":"NCT01514227","phase":"PHASE4","title":"Nobori Dual Antiplatelet Therapy as Appropriate Duration","status":"COMPLETED","sponsor":"Associations for Establishment of Evidence in Interventions","startDate":"2011-12","conditions":"Coronary Artery Disease","enrollment":3773},{"nctId":"NCT01325935","phase":"PHASE4","title":"Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients","status":"COMPLETED","sponsor":"Associations for Establishment of Evidence in Interventions","startDate":"2011-04","conditions":"Coronary Artery Disease","enrollment":1187}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":111,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["3 months ASA + Clopidogrel"],"phase":"phase_3","status":"active","brandName":"Short DAPT","genericName":"Short DAPT","companyName":"Korea University Guro Hospital","companyId":"korea-university-guro-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Short DAPT involves a reduced duration of dual antiplatelet therapy to minimize bleeding risks while maintaining cardiovascular protection. Used for Atrial fibrillation for stroke prevention, Acute coronary syndrome.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}